Engineered 3D bioimplants using elastomeric scaffold, self-assembling peptide hydrogel, and adipose tissue-derived progenitor cells for cardiac regeneration

American Journal of Translational Research

Volumn 6, Issue 3, 2014, Pages 291-301

  Soler Botija, Carolina ^a   Bagó, Juli R ^b   Llucià Valldeperas, Aida ^a   Vallés Lluch, Ana ^c   Castells Sala, Cristina ^d   Martínez Ramos, Cristina ^c   Fernández Muiños, Teresa ^d   Chachques, Juan Carlos ^e   Pradas, Manuel Monleón Pradas ^c   Semino, Carlos E ^d   Bayes Genis, Antoni ^a,f  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^d Institut Químic de Sarrià Universitat Ramon Llull   (Spain)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cardiac regeneration; Elastomeric membrane; RECATABI; Self assembling peptide hydrogel; Subcutaneous ATDPCs

Indexed keywords

ELASTOMERIC SCAFFOLD; FLUORESCEIN ISOTHIOCYANATE; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; POLYCAPROLACTONE; POLYCAPROLACTONE METHACRYLOYLOXYETHYL ESTER; SELF ASSEMBLED MONOLAYER; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ADIPOSE TISSUE CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOIMPLANT; BIOLUMINESCENCE; CARDIAC IMPLANT; CARDIAC REGENERATION; CARDIAC TROPONIN 1 CLIA KIT; CELL SELECTION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HEART FUNCTION; HEART INFARCTION; HISTOLOGY; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PEPTIDE HYDROGEL; PROTEIN EXPRESSION; TISSUE REGENERATION;

EID: 84901000464     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 1991; 68: 856-869.
2. Anversa P, Leri A, Kajstura J. Cardiac regeneration. J Am Coll Cardiol 2006; 47: 1769-1776.
3. Parmacek MS, Epstein JA. Cardiomyocyte renewal. N Engl J Med 2009; 361: 86-88.
4. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisén J. Evidence for cardiomyocyte renewal in humans. Science 2009; 324: 98-102.
5. Genovese J, Cortes-Morichetti M, Chachques E, Frati G, Patel A, Chachques JC. Cell based approaches for myocardial regeneration and artificial myocardium. Curr Stem Cell Res Ther 2007; 2: 121-127.
6. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann NY Acad Sci 2001; 938: 221-229.
7. Schuleri KH, Amado LC, Boyle AJ, Centola M, Saliaris AP, Gutman MR, Hatzistergos KE, Oskouei BN, Zimmet JM, Young RG, Heldman AW, Lardo AC, Hare JM. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 2008; 294: H2002-H2011.
8. Flynn A, O'Brien T. Stem cell therapy for cardiac disease. Expert Opin Biol Ther 2011; 11: 177-187.
9. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148.
10. Kang HJ, Lee HY, Na SH, Chang SA, Park KW, Kim HK, Kim SY, Chang HJ, Lee W, Kang WJ, Koo BK, Kim YJ, Lee DS, Sohn DW, Han KS, Oh BH, Park YB, Kim HS. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colonystimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction. The MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006; 114: I145-51.
11. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-1221.
12. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367: 113-121.
13. Leistner DM, Fischer-Rasokat U, Honold J, Seeger FH, Schächinger V, Lehmann R, Martin H, Burck I, Urbich C, Dimmeler S, Zeiher AM, Assmus B. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy. Clin Res Cardiol 2011; 100: 925-934.
14. Zhang H, Chen H, Wang W, Wei Y, Hu S. Cell survival and redistribution after transplantation into damaged myocardium. J Cell Mol Med 2010; 14: 1078-1082.
15. Mooney DJ, Vandenburgh H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2008; 2: 205-213.
16. Soler-Botija C, Galvez-Monton, C, Prat-Vidal C, Roura S, Bayes-Genis A. Myocardial bioprosthesis: Mimicking nature. Drugs Fut 2013; 38: 475-484.
17. Vunjak-Novakovic G, Lui KO, Tandon N, Chien KR. Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Pev Biomed Eng 2011; 13: 245-267.
18. Soler-Botija C, Bago JR, Bayes-Genis A. A bird'seye view of cell therapy and tissue engineering for cardiac regeneration. Ann N Y Acad Sci 2012; 1254: 57-65.
19. Gálvez-Montón C, Prat-Vidal C, Roura S, SolerBotija C, Bayes-Genis A. Cardiac Tissue Engineering and the Bioartificial Heart. Rev Esp Cardiol 2013; 66: 391-399.
20. Shafy A, Fink T, Zachar V, Lila N, Carpentier A, Chachques JC. Development of cardiac support bioprostheses for ventricular restoration and myocardial regeneration. Eur J Cardiothorac Surg 2013; 43: 1211-1219.
21. Ivirico JL, Martínez EC, Sánchez MS, Criado IM, Ribelles JL, Pradas MM. Structure and properties of methacrylate-endcapped caprolactone networks with modulated water uptake for biomedical applications. J Biomed Mater Res B Appl Biomater 2007; 83: 266-275.
22. Léobon B, Roncalli J, Joffre C, Mazo M, Boisson M, Barreau C, Calise D, Arnaud E, André M, Pucéat M, Pénicaud L, Prosper F, Planat-Bénard V, Casteilla L. Adipose-derived cardiomyogenic cells: in vitro expansion and functional improvement in a mouse model of myocardial infarction. Cardiovasc Res 2009; 83: 757-767.
23. Bagó JR, Soler-Botija C, Casaní L, Aguilar E, Alieva M, Rubio N, Bayes-Genis A, Blanco J. Bioluminescence imaging of cardiomyogenic and vascular differentiation of cardiac and subcutaneous adipose tissue-derived progenitor cells in fibrin patches in a myocardium infarct model. Int J Cardiol 2013; 69: 288-295.
24. Vallés-Lluch A, Arnal-Pastor M, Martínez-Ramos C, Vilariño-Feltrer G, Vikingsson L, Castells-Sala C, Semino CE, Monleón Pradas M. Combining self-assembling peptide gels with three-dimensional elastomer scaffolds. Acta Biomater 2013; 9: 9451-9460.
25. Bayes-Genis A, Soler-Botija C, Farré J, Sepúlveda P, Raya A, Roura S, Prat-Vidal C, Gálvez-Montón C, Montero JA, Büscher D, Izpisúa Belmonte JC. Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. J Mol Cell Cardiol 2010; 49: 771-780.
26. Martinez-Estrada OM, Munoz-Santos Y, Julve J, Reina M, Vilaro S. Human adipose tissue as a source of Flk-1+ cells: new method of differentiation and expansion. Cardiovasc Res 2005; 65: 328-333.
27. Vilalta M, Jorgensen C, Dégano IR, Chernajovsky Y, Gould D, Noël D, Andrades JA, Becerra J, Rubio N, Blanco J. Dual luciferase labelling for non-invasive bioluminescence imaging of mesenchymal stromal cell chondrogenic differentiation in demineralized bone matrix scaffolds. Biomaterials 2009; 30: 4986-4995.
28. Kraehenbuehl TP, Langer R, Ferreira LS. Three-dimensional biomaterials for the study of human pluripotent stem cells. Nat Methods 2011; 8: 731-736.
29. Chachques JC, Pradas MM, Bayes-Genis A, Semino C. Creating the bioartificial myocardium for cardiac repair: challenges and clinical targets. Expert Rev Cardiovasc Ther 2013; 11: 1701-1711.
30. Salazar Y, Bragos R, Casas O, Cinca J, Rosell J. Transmural versus nontransmural in situ electrical impedance spectrum for healthy, ischemic, and healed myocardium. IEEE Trans Biomed Eng 2004; 51: 1421-1427.
31. Valdes-Sánchez T, Rodriguez-Jimenez FJ, García-Cruz DM, Escobar-Ivirico JL, Alastrue-Agudo A, Erceg S, Monleón M, Moreno-Manzano V. Methacrylate-endcapped caprolactone and FM19G11 provide a proper niche for spinal cord-derived neural cells. J Tissue Eng Regen Med 2013; [Epub ahead of print].
32. Zhao X, Zhang S. Self-assembling nanopeptides become a new type of biomaterial. Adv Polym Sci 2006; 203: 145-170.
33. Quintana L, Fernández Muiños T, Genové E, Olmos MM, Borrós S, Semino CE. Early tissue patterning recreated by mouse embryonic fibroblasts in a three dimensional environment. Tissue Eng Part A 2009; 15: 45-54.
34. Ortinau S, Schmich J, Block S, Liedmann A, Jonas L, Weiss DG, Helm CA, Rolfs A, Frech MJ. Effect of 3D scaffold formation on differentiation and survival in human neural progenitor cells. Biomed Eng Online 2010; 9: 70.
35. Thonhoff JR, Lou DI, Jordan PM, Zhao X, Wu P. Compatibility of human fetal neural stem cells with hydrogel biomaterials in vitro. Brain Res 2008; 1187: 42-51.
36. Castells-Sala C, Sanchez B, Recha-Sancho L, Puig V, Bragos R, Semino CE. Influence of electrical stimulation on 3D-cultures of adipose tissue derived progenitor cells (ATDPCs) behavior. Conf Proc IEEE Eng Med Biol Soc 2012; 2012: 5658-5661.
37. Cui XJ, Xie H, Wang HJ, Guo HD, Zhang JK, Wang C, Tan YZ. Transplantation of mesenchymal stem cells with self-assembling polypeptide scaffolds is conducive to treating myocardial infarction in rats. Tohoku J Exp Med 2010; 222: 281-289.
38. Hsieh PC, Davis ME, Gannon J, MacGillivray C, Lee RT. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 2006; 116: 237-248.
39. Tokunaga M, Liu ML, Nagai T, Iwanaga K, Matsuura K, Takahashi T, Kanda M, Kondo N, Wang P, Naito AT, Komuro I. Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction. J Mol Cell Card 2010; 49: 972-983.
40. Genové E, Shen C, Zhang S, Semino CE. The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials 2005; 26: 3341-3351.
41. Sieminski AL, Semino CE, Gong H, Kamm RD. Primary sequence of ionic selfassembling peptide gels affects endothelial cell adhesion and capillary morphogenesis. J Biomed Mater Res Part A 2008; 87: 494-504.
42. Puett DW, Forman MB, Cates CU, Wilson BH, Hande KR, Friesinger GC, Virmani R. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion. Circulation 1987; 76: 678-686.
43. Prat-Vidal C, Gálvez-Montón C, Nonell L, Puigdecanet E, Astier L, Solé F, Bayes-Genis A. Identification of temporal and region-specific myocardial gene expression patterns in response to infarction in swine. PLoS One 2013; 8: e54785.